TrialDiabetes technology & therapeutics2020

Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart (NovoLog) When Used in Insulin Pumps in Adults with Type 1 Diabetes: A Randomized, Open-Label Clinical Trial.

James Thrasher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.